New Supply of CroFab™ Snakebite Antivenom Shipping This Week.

Melville, NY – August 13, 2002 – Savage Laboratories®, the pharmaceutical division of Altana Inc., announced today that the Food and Drug Administration has released 2,718 vials (1,359 cartons) of CroFab^TM; (Crotalidae Polyvalent Immune Fab -- Ovine) for shipment immediately. The shipments represent the fourth shipment of CroFab^TM this year. Hospitals and poison centers should contact wholesale distributors directly for local availability.

CroFab^TM; is indicated for the management of patients with minimal or moderate North American crotalid envenomation. The term crotalid describes the Crotalidae family of venomous snakes, which includes rattlesnakes, copperheads and cottonmouths/water moccasins. CroFab^TM; was developed and is manufactured by Protherics PLC.

About Savage Labs
Savage Laboratories® is a division of Altana, Inc., the U.S. subsidiary of Byk-Gulden, a multi-national pharmaceutical company based in Konstanz, Germany. Currently the strategic focus of Savage Laboratories is emergency/critical care and women’s health care. More information is available at www.savagelabs.com.

CONTACT: Russell LaMontagne of Corinth Group Communications, for Savage Laboratories(R), 212/255-5340